LipidLover

@LipidLover1030

No LDL-C level is too low

Vrijeme pridruživanja: ožujak 2018.

Tweetovi

Blokirali ste korisnika/cu @LipidLover1030

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @LipidLover1030

  1. proslijedio/la je Tweet
    4. velj

    All w/ accepted abstracts at - the section is giving away 3 travel awards! Apply👇🏽for this prestigious award! 🌟

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 21 sat

    Happy ! PACH is joining @WomenHeartNatl in its annual campaign to raise awareness about heart disease in African American women.

    Poništi
  3. proslijedio/la je Tweet
    29. sij

    Science Translational Medicine- published today-exciting new data on ApoC2 peptide to dually antagonize ApoC3 and activate LPL as a therapeutic to rapidly decrease TG levels in preclinical models- winner of the Orloff NIH award-

    Poništi
  4. proslijedio/la je Tweet
    28. sij
    Odgovor korisnicima

    Thank you so much . Certainly a highlight of my trip was getting to catch with you and all the amazing work you are doing. I love following your career. Keep shining bright! 🌟

    Poništi
  5. proslijedio/la je Tweet
    28. sij

    Masterful rounds this AM on CVD in women - Despite overlap in sx, women have unique CV risks/challenges. Thanks for showing us how we can ensure women receive optimal CV care.

    Poništi
  6. proslijedio/la je Tweet
    27. sij

    ASPC offers FREE membership to fellows in training! Join world renowned CVD prevention experts, mentors & colleagues. Our annual meeting is fantastic! Please share with any interested fellows.

    Poništi
  7. proslijedio/la je Tweet
    21. sij

    HRRP. Hospitals with ⬇️ in readmissions had the highest 30 day mortality, continued to rise. All hospitals exposed, ⬆️ deaths. Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA

    Poništi
  8. proslijedio/la je Tweet

    We are proud to announce that Congress recognized the public health impact early identification of FH and intervention can make. FH made it into the Federal budget as a result of our efforts! Blog:

    Poništi
  9. proslijedio/la je Tweet
    25. sij

    A piece of art, a must read article 👏👏👏 Written by a Dream Team in FH. Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

    , , i još njih 3
    Poništi
  10. proslijedio/la je Tweet
    17. sij

    "It would shock me if anybody could write a big enough check to make sense to our shareholders," Arrowhead's CEO told me. Read my latest on the exploding RNAi space of and :

    Poništi
  11. proslijedio/la je Tweet
    20. sij

    Really pleased for my visiting fellow DrJulia Brandts who had her first publication with us. A novel concept for public health “The cumulative exposure model” published ahead of print in Circulation today. Here is the key figure

    Poništi
  12. 15. sij

    With Novartis now owning inclisiran as well, if this is ready by 2025, they will have quite a powerful duo in lipid management. 👍👍

    Poništi
  13. proslijedio/la je Tweet
    14. sij

    Excited to watch - a great start by to focus on access ASAP. Thrilled to see primary prevention study launching. This drug at a population level has massive potential and could change the landscape of CV disease.

    Poništi
  14. proslijedio/la je Tweet
    14. sij

    BBC World news talking about this game changer

    Poništi
  15. 14. sij

    Look who’s on the cover of the Jan\Feb edition of Cardiovascular Business! Article discussing CV risk and brain disease and role of cardiologists to reduce all risk. Important read.

    Poništi
  16. 14. sij

    50-55% ⬇️ in LDL-C w 2 x PER YEAR dosing vs. 24 x per year dosing. And, drug admin in front of clinician so adherence should be 95%+ for EVERY appropriate patient type. Cost of non-adherence is millions. Move on to 2020 & leave 30 years of non adherence behind. Great for 🏴󠁧󠁢󠁥󠁮󠁧󠁿

    Poništi
  17. proslijedio/la je Tweet
    13. sij

    Interested in an opportunity to network with colleagues? 🙋 The NLA’s Women in Lipidology group will meet for drinks @ Grand Hyatt’s Fireside Bar on Sat, Feb 29, 7 – 7:30pm & New Member Game Night will kickoff at 7:30pm that same night at ! 👉

    Poništi
  18. 13. sij

    Amazing once again - for these FH patients to be identified and treated by you, and the power of the PCSK9i MABs. So sad they are still very difficult to be approved for all of us.

    Poništi
  19. proslijedio/la je Tweet
    13. sij

    Huge disappointment for CV prevention today esp for those w high . In light of conflicting results from REDUCE-IT & STRENGTH, expecting much more science on DHA vs EPA. THIS is why we do RCTs.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·